Clinical Trials Browser

Active not recruiting × OTHER × Carcinoma, Renal Cell × Clear all

NCT02713269 2026-04-17

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Phase 2 Active not recruiting

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Sarcoma, Spinal Cord Compression, Thyroid Neoplasms

NCT01590069 2026-04-16

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

Phase 1 Active not recruiting

DermatologicGenitourinarySarcoma

Carcinoma, Renal Cell, Melanoma, Sarcoma, Osteosarcoma

NCT00918775 2026-04-15

Follow-up After Metastasectomy in Patients With Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT06049576 2026-04-15

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 1 Active not recruiting

Carcinoma, Renal Cell

NCT05808608 2026-04-07

A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT05703269 2026-04-06

HYPOGRYPHE

Phase NA Active not recruiting

BreastCNSDermatologicGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Small Cell Lung Carcinoma

NCT02664883 2026-04-02

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Active not recruiting

Carcinoma, Renal Cell

NCT04788095 2026-03-24

App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer

Phase NA Active not recruiting

Carcinoma, Renal Cell

NCT06126159 2026-03-20

MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers

Phase NA Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms, Angiomyolipoma

NCT05012371 2026-03-05

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Phase 2 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05122546 2026-03-05

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Phase 1 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT06284564 2026-03-04

A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT01684397 2026-02-27

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT06964958 2026-02-24

LASER

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04258462 2026-02-23

Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04258813 2026-02-20

ONE TEAM

Phase NA Active not recruiting

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04919122 2026-02-11

ODYSSEY RCC

Active not recruiting

Carcinoma, Renal Cell

NCT05863052 2026-02-10

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Active not recruiting

DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis

NCT01217931 2026-01-30

Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Phase 2 Active not recruiting

157 enrolled 26 charts

CNSEndocrineGenitourinary

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

NCT03474497 2026-01-29

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Phase 1/2 Active not recruiting

18 enrolled 13 charts

DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT02432963 2026-01-28

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Phase 1 Active not recruiting

BreastDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Triple Negative Breast Neoplasms

NCT04413123 2026-01-21

Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT02473536 2026-01-16

Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT05239533 2026-01-14

Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05501054 2026-01-14

Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT07332923 2026-01-12

Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

Active not recruiting

Carcinoma, Renal Cell

NCT03541902 2026-01-09

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Phase 2 Active not recruiting

Carcinoma, Renal Cell, Urologic Neoplasms

NCT03587662 2026-01-09

Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT02210117 2026-01-07

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Renal Cell

NCT04022343 2026-01-05

Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Phase 2 Active not recruiting

22 enrolled 16 charts

Carcinoma, Renal Cell

NCT03630536 2025-12-30

TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

Active not recruiting

Carcinoma, Renal Cell

NCT06339138 2025-12-24

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Active not recruiting

Oncocytoma, renal, Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT00715442 2025-12-23

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT03092856 2025-12-17

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT05363631 2025-12-10

Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab

Phase 1/2 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT04388852 2025-11-21

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Phase 1 Active not recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Neoplasm Metastasis, Prostatic Neoplasms

NCT06132945 2025-11-14

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

Phase 1 Active not recruiting

CNSGenitourinary

Brain Neoplasms, Carcinoma, Renal Cell

NCT01224288 2025-11-10

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

NCT06630429 2025-11-10

A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors

Active not recruiting

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT04074967 2025-11-06

Study of ARRY-614 Plus Either Nivolumab or Nivolumab+Ipilimumab

Phase 1/2 Active not recruiting

DermatologicGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT04620603 2025-11-06

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Phase 1 Active not recruiting

DermatologicGenitourinary

Melanoma, Cutaneous Malignant, Carcinoma, Renal Cell

NCT04495257 2025-10-30

A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

Phase 1 Active not recruiting

Carcinoma, Renal Cell

NCT03172754 2025-10-29

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell

NCT03728842 2025-10-27

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Active not recruiting

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Neoplasm Metastasis, Remission, Spontaneous

NCT03438708 2025-10-02

PADRES

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT05148546 2025-09-30

NESCIO

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT04687969 2025-09-25

Multimodal Machine Learning Characterization of Solid Tumors

Active not recruiting

CNSGastrointestinalGenitourinary

Carcinoma, Renal Cell, Glioma, Carcinoma, Hepatocellular, Prostatic Neoplasms

NCT03635892 2025-09-22

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT06917560 2025-09-18

Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study

Active not recruiting

Carcinoma, Renal Cell